Exagen (XGN) Free Cash Flow (2018 - 2026)

Exagen (XGN) has reported Free Cash Flow for 9 consecutive years, with -$10.6 million the latest figure, recorded in Q1 2026.

• Free Cash Flow for Q1 2026 came in at -$10.6 million, up 1.29% year-over-year; the trailing twelve-month figure through Mar 2026 was -$14.1 million (up 8.57% YoY), and the FY2025 annual result was -$14.3 million, down 3.42% from the prior year.
• Free Cash Flow was -$10.6 million for Q1 2026 at Exagen, down from -$3.6 million in the prior quarter.
• Over five years, Free Cash Flow peaked at $9.0 million in Q4 2023 and troughed at -$13.1 million in Q2 2022.
• Average Free Cash Flow over 5 years is -$5.3 million, with a median of -$6.1 million recorded in 2022.
• Year-over-year, Free Cash Flow jumped 246.66% in 2023 and slumped 1776.04% in 2025.
• Over 5 years, Free Cash Flow stood at -$6.1 million in 2022, then surged by 246.66% to $9.0 million in 2023, then slumped by 97.59% to $217000.0 in 2024, then plunged by 1776.04% to -$3.6 million in 2025, then tumbled by 192.69% to -$10.6 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were -$10.6 million in Q1 2026, -$3.6 million in Q4 2025, and $3.2 million in Q3 2025.